MICROMET, INC. Clinical Trials
Studies registered on ClinicalTrials.gov (U.S. National Library of Medicine) with the company as lead sponsor or collaborator, newest start first. Values are as registered.
- 2005-07: Study NCT00128583; Company role Lead sponsor; Phase Phase 2; Status Unknown.
- NCT00052156: Company role Lead sponsor; Phase Phase 3; Status Unknown.
- NCT00052130: Company role Lead sponsor; Phase Phase 3; Status Unknown.
| Start date | Study | Company role | Phase | Status | Conditions | Enrollment | Completion date |
|---|---|---|---|---|---|---|---|
| 2005-07 | NCT00128583 Vaccine Therapy in Treating Patients With Malignant Melanoma | Lead sponsor | Phase 2 | Unknown | Melanoma (Skin) | ||
| NCT00052156 Vaccine Therapy for Patients With Stage IV Melanoma | Lead sponsor | Phase 3 | Unknown | Malignant Melanoma | 670 | ||
| NCT00052130 Vaccine Therapy for Patients With Stage III Melanoma | Lead sponsor | Phase 3 | Unknown | Malignant Melanoma | 1,118 |